In January, the U.S. Supreme Court is slated to hear two cases brought by fishing companies that, at first glance, would seem to have nothing to do with health insurers. However, the outcome of those cases could profoundly change how insurers — and companies of all stripes — interact with the many regulations that govern their businesses.
That’s because the cases — Loper Bright Enterprises, et al. v. Gina Raimondo and Relentless Inc., et al. v. Dept. of Commerce, et al — concern a legal doctrine known as Chevron deference, which for decades has given federal agencies considerable leeway when interpreting laws via rulemaking. If the high court strikes down that longstanding legal precedent, the regulatory landscape that governs every industry could become much more chaotic, legal experts tell AIS Health, a division of MMIT.